Interface Biologics Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Interface Biologics Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6468
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Interface Biologics Inc (IBI) is a medical device company that develops transformative biomedical polymer technologies. The company offers anti-thrombogenic and combination drug delivery devices. Its anti-thrombogenic additives reduce thrombosis in blood contacting medical devices and polymer enabled drug delivery platforms. IBI’s technologies include endexo, kinesyx and epidel. The company provides combination drug delivery devices which include Epidel and Kinesyx. Its products improve the safety and effectiveness of implantable medical devices. The company serves dialysis patients in Canada and abroad. IBI is headquartered in Toronto, Ontario, Canada.

Interface Biologics Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Interface Biologics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Interface Biologics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Interface Biologics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Interface Biologics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Interface Biologics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Interface Biologics Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Interface Biologics Raises Funds Through Extended Series B Venture Financing 10
Partnerships 11
AngioDynamics Extends Licensing Agreement With Interface Biologics To Include Central Venous Catheters 11
Interface Biologics To Enter Into Co-Development Agreement With Qualimed Innovative Medizinprodukte 12
Interface Biologics Inc – Key Competitors 13
Interface Biologics Inc – Key Employees 14
Interface Biologics Inc – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Interface Biologics Inc, Medical Equipment, Key Facts 2
Interface Biologics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Interface Biologics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Interface Biologics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Interface Biologics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Interface Biologics Inc, Deals By Market, 2012 to YTD 2018 8
Interface Biologics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Interface Biologics Raises Funds Through Extended Series B Venture Financing 10
AngioDynamics Extends Licensing Agreement With Interface Biologics To Include Central Venous Catheters 11
Interface Biologics To Enter Into Co-Development Agreement With Qualimed Innovative Medizinprodukte 12
Interface Biologics Inc, Key Competitors 13
Interface Biologics Inc, Key Employees 14

List of Figures
Interface Biologics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Interface Biologics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Interface Biologics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Interface Biologics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Interface Biologics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Interface Biologics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Interface Biologics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Interface Biologics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Interface Biologics Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • MITIE Group Plc (MTO):企業の財務・戦略的SWOT分析
    MITIE Group Plc (MTO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Kering SA:企業のM&A・事業提携・投資動向
    Kering SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Kering SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Dicerna Pharmaceuticals, Inc.:企業のM&A・事業提携・投資動向
    Dicerna Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Dicerna Pharmaceuticals, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Tata Consultancy Services Limited:企業の戦略・SWOT・財務分析
    Tata Consultancy Services Limited - Strategy, SWOT and Corporate Finance Report Summary Tata Consultancy Services Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Saipem SpA (SPM)-石油・ガス分野:企業M&A・提携分析
    Summary Saipem SpA (Saipem) is an engineering, procurement, construction (EPC) contractor. It provides integrated basic design, Pre-front end engineering design (FEED), FEED and detailed EPC and project management services for complex offshore and onshore projects in the oil and gas industry. The co …
  • Egton Medical Information Systems Ltd (EMIS)-医療機器分野:企業M&A・提携分析
    Summary Egton Medical Information Systems Ltd (EMIS) is a medical technology company that develops and offers software solutions for the healthcare industry. The company offers software products such as EMIS web, which is used for clinical services; EMIS IQ for data extraction services; symphony tha …
  • Hitachi Zosen Corporation:戦略・SWOT・企業財務分析
    Hitachi Zosen Corporation - Strategy, SWOT and Corporate Finance Report Summary Hitachi Zosen Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Redcape Hotel Group:企業の戦略・SWOT・財務情報
    Redcape Hotel Group - Strategy, SWOT and Corporate Finance Report Summary Redcape Hotel Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • MiMedx Group Inc – Product Pipeline Analysis, 2018 Uate
    Summary MiMedx Group Inc (MiMedx) is a biopharmaceutical company that develops, manufactures and markets regenerative biologics utilizing human placental allografts. The company provides products such as amniotic membrane, umbilical cord, placental ECM and amniotic fluid. It utilizes proprietary pur …
  • Five Star Senior Living Inc (FVE):企業の財務・戦略的SWOT分析
    Summary Five Star Senior Living Inc (Five Star), formerly Five Star Quality Care Inc is a healthcare service provider that offers senior living and patient care services. The center’s services include independent living, assisted living, skilled nursing care, memory care, dining and nutrition, hospi …
  • Voyager Therapeutics Inc (VYGR):企業の財務・戦略的SWOT分析
    Summary Voyager Therapeutics Inc (Voyager) is a gene therapy company that discovers, develops and commercializes therapies to treat severe neurological diseases. It is evaluating VY-AADC program for the treatment of advanced Parkinson’s disease; VY-SOD102 against monogenic amyotrophic lateral sclero …
  • Illinois Municipal Electric Agency:企業の戦略的SWOT分析
    Illinois Municipal Electric Agency - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Vertex Pharmaceuticals Inc (VRTX):企業の財務・戦略的SWOT分析
    Vertex Pharmaceuticals Inc (VRTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Helomics Corp:医療機器:M&Aディール及び事業提携情報
    Summary Helomics Corp (Helomics) is a life science company that develops and offers precision medicine support tools and services for cancer treatment. The company’s products include chemofx, biospecifx, genefx colon and genefx lung. Its chemofx is a drug response marker, which is used to test tumor …
  • City Developments Ltd:戦略・SWOT・企業財務分析
    City Developments Ltd - Strategy, SWOT and Corporate Finance Report Summary City Developments Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Hayashibara Co Ltd:企業の戦略的SWOT分析
    Hayashibara Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Zenotech Laboratories Ltd (532039):企業の財務・戦略的SWOT分析
    Zenotech Laboratories Ltd (532039) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Arno Therapeutics Inc (ARNI)-医療機器分野:企業M&A・提携分析
    Summary Arno Therapeutics Inc (Arno) is a clinical stage biopharmaceutical company that develops products for the treatment of cancer, infectious diseases and other life threatening diseases. The company has exclusive worldwide rights for the development and commercialization of Onapristone (for the …
  • Westrock Company:企業の戦略・SWOT・財務情報
    Westrock Company - Strategy, SWOT and Corporate Finance Report Summary Westrock Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Kaken Pharmaceutical Co Ltd (4521):企業の財務・戦略的SWOT分析
    Kaken Pharmaceutical Co Ltd (4521) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆